ClinicalTrials.gov
public full text
Public Domain
Blood Samples to Evaluate Biomarkers of Donor Chimerism
We are interested in patient-specific factors that may affect the balance of recipient cells and donor cells in patients who receive stem cell transplants. We will look at the way the patient's body breaks down two drugs, fludarabine and mycophenolate mofetil, and how these two drugs affect the patient's body.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test#1351913
- Experimentelle Herstellung geformter, granulärer, HHD-prozessierter, knöcherner Allografts zur gesteuerten Hartgeweberegeneration in der MKG-Chirurgie#339094
- Xenophagocytosis blockade enhances interspecies chimerism#485199
- The Connection Between Liver Disease and Chitinase Proteins#651164
- A Prospective Randomized Trial on Mycophenolate Mofetil in Risk Penetrating Keratoplasty#862976
Record · ID 1262940
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive